Victoria Files
Family · Edmond, OKNPI 1992020465
Payments from drug & device makers
Across 121 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$671
- Novo Nordisk$444
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$266
- Takeda Pharmaceuticals U.S.A., Inc.$132
- Corcept Therapeutics$127
- IBSA Pharma Inc.$100
- plus $512 from 14 others
What the payments were for
- Food & beverage$2,252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $671 |
| Novo Nordisk | 29 | $444 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $266 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $132 |
| Corcept Therapeutics | 6 | $127 |
| IBSA Pharma Inc. | 6 | $100 |
| Revance Therapeutics, Inc. | 4 | $99 |
| Amneal Pharmaceuticals LLC | 5 | $86 |
| Lilly USA, LLC | 4 | $65 |
| Pfizer | 3 | $56 |
| Currax Pharmaceuticals LLC | 4 | $51 |
| Vivus LLC | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Abbott | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$149
How this compares
$2,252 in reported general payments places this provider in the 80th percentile of 2,026 family providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $22,910 |
| MounjaroTirzepatide | 21 | $22,282 |
| ProgesteroneProgesterone, Micronized | 72 | $2,394 |
| Np ThyroidThyroid,pork | 36 | $1,843 |
| Liothyronine Sodium | 16 | $1,365 |
| SynthroidLevothyroxine Sodium | 13 | $1,276 |
| Levothyroxine Sodium | 20 | $727 |
| Bupropion XlBupropion Hcl | 17 | $699 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $615 |
| Duloxetine Hcl | 20 | $377 |
| Spironolactone | 21 | $363 |
| Atorvastatin Calcium | 19 | $216 |
| RizatriptanRizatriptan Benzoate | 11 | $160 |
| Trazodone Hcl | 14 | $121 |
| Tizanidine Hcl | 12 | $90 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $444 | $22,91025 claims |
| Lilly USA, LLCMounjaro | $65 | $22,28221 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $15 | $1,84336 claims |
| AbbVieSynthroid | $671 | $1,27613 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $86 | $72720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,026 family providers in Oklahoma.
Other family in Edmond
- Wendy ParksEdmond$11K
- Allison DuncanEdmond$7K
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Shelby WrightStillwater$17K
- Brandy ReevesNorman$17K
- Amanda OblanderYukon$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.